‘Most exciting cancer treatment since chemotherapy’ could save patients using DNA tests

    ‘New era’ of personalised cancer drugs, say doctors

    A novel p53-Cdc7 link induced by genotoxic stress

    Abarelix for injectable suspension

    Abiraterone acetate

    Ado-trastuzumab emtansine

    Adrenocortical carcinoma

    Afatinib

    Alectinib

    Alfuzosin Hydrochloride

    AML and chemotherapy. A study recently co-authored by Oncologica

    Anal cancer

    Anaplastic astrocytoma

    Aprepitant

    Axitinib

    Basal-cell carcinoma

    Bevacizumab

    Bevacizumab

    Bevacizumab

    Binimetinib Improves PFS in NRAS-mutant Melanoma

    Bladder cancer

    Bone tumour

    Bortezomib

    Brain Tumor

    Brainstem glioma

    Breast Cancer

    Cabazitaxel

    Cabozantinib

    Cancer treatment untested in many patients with immune problems

    Capecitabine

    Cdc7 is a potent anti-cancer target in pancreatic cancer due to abrogation of the DNA origin activation checkpoint

    Cell cycle status in AML blast cells from peripheral blood, bone marrow aspirates and trephines and implications for biological studies and treatment

    Ceritinib

    Cervical cancer

    Cervical intraepithelial neoplasia

    Cetuximab

    Chemotherapy is no longer the only option against cancer…

    Cholangiocarcinoma

    Cinacalcet

    Cobimetinib

    Colorectal cancer

    Coming ever closer – first PARP inhibitor licensed in Europe

    Conjugated estrogens

    Consensus on genomic classification of bladder cancer makes progress

    Crizotinib

    Dabrafenib

    Dad with terminal cancer given hope by ground-breaking precision oncology test

    Defining cancers based on genetic ‘fingerprint’ could help personalise treatment

    Degarelix for injection

    Denosumab

    Denosumab

    Dinutuximab

    DNA ‘barcode’ delivering personalised breast cancer care

    Docetaxel

    Doxorubicin HCl liposome injection

    Efficacy of Osimertinib in Advanced T790M-positive NSCLC

    Endometrial cancer

    Enzalutamide

    Epirubicin hydrochloride

    Eribulin mesylate

    Erlotinib

    Esophageal cancer

    Everolimus

    Everolimus

    Everolimus

    Everolimus

    Every cancer patient could have DNA tested under five-year government plan to cut deaths

    Every child with cancer to have tumour DNA sequenced to find best treatment

    Ewing’s sarcoma

    Exemestane

    Fallopian tube cancer

    Fentanyl buccal

    Fentanyl citrate

    Fentanyl sublingual spray

    Fentanyl sublingual tablets

    Ferumoxides

    Frontline Pembrolizumab Combo Approved by FDA for NSCLC

    Fulvestrant

    Gallbladder cancer

    Gastric cancer

    Gefitinib

    Gemcitabine HCL

    Genetic testing of tumours could personalise cancer treatment, experts say

    Germ cell tumor

    Giant-cell tumor of bone

    GIST

    Glioblastoma

    Goserelin acetate implant

    Granisetron

    Granisetron

    Groundbreaking discovery made use skin cells to kill cancer

    Human Papillomavirus Bivalent

    Hypopharyngeal cancer

    Ibritumomab tiuxetan

    Imatinib and GISTs: Genomic Subtypes and Survival Outcomes

    Imatinib mesylate

    Imiquimod

    Immunotherapy, Molecular Testing Propel Dramatic Changes in Lung Cancer Care

    Improving Patient Education and Access: How Can We Better Leverage Advances in Cancer Diagnostics and Treatment

    Iodixanol

    Ipilimumab

    Irinotecan liposome injection

    Ixabepilone

    Kaposi’s sarcoma

    Kidney cancer

    Lapatinib

    Laryngeal cancer

    Leiomyosarcoma

    Lenvatinib

    Letrozole

    Leuprolide acetate

    Leuprolide Acetate

    Levoleucovorin

    Liposarcoma

    Liver cancer

    Lung Cancer

    Lung Cancer Driver Discovery May Lead to Novel Therapy for Some Mesothelioma Patients

    Malignant rhabdoid tumour

    Mechlorethamine

    Melanoma

    Merkel-cell carcinoma

    Mesothelioma

    Mesothelioma shows promising response to existing immunotherapy drug

    Model shows cancer’s birth and spread from single cell

    Mutation-Targeted Therapy Slows Lung Cancer (NSCLC)

    Mycosis fungoides

    Nasopharynx cancer

    Necitumumab

    Neuroblastoma

    New biomarker identifies uveal melanoma patients at high risk for metastasis

    New Insights Into Rucaparib Activity in Ovarian Cancer

    NHS should give all cancer patients personalised care

    NICE says yes to Novartis’ Afinitor in kidney cancer

    Nivolumab

    Nivolumab

    Olaparib

    Olaratumab May Improve Disease Control in Certain Patients With GIST

    OncoCheckpoint: Companion DX for Cdc7 inhibitors

    Oncofocus a revolutionary test that can tailor the best therapy for cancer patients

    Oncofocus Cancer Test and targeted therapies. The Revolution in cancer treatment has begun.

    Oncologica live on The Pat Kenny Show – IRELAND

    Oncologica Ltd. to open lab in Dublin

    Oncologica UK contributes to setting new guidelines for implementation of Next Generation Sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours. An expert opinion on behalf of IQN Path ASBL.

    Ondansetron oral soluble film

    Oropharyngeal cancer

    Osimertinib

    Osteosarcoma

    Ovarian Cancer

    Oxaliplatin

    p53 controls CDC7 levels to reinforce G1 cell cycle arrest upon genotoxic stress.

    Paclitaxel

    Paclitaxel protein-bound particles for injectable suspension

    Palbociclib

    Palonosetron

    Pancreatic cancer

    Pancreatic cancer found to be four separate diseases

    Pancreatic neuroendocrine tumors

    Panitumumab

    Paraganglioma

    Parathyroid carcinoma

    PAT KENNY SHOW talk available as podcast

    Pazopanib

    Pazopanib

    Pegfilgrastim

    Peginterferon alfa-2b

    Pembrolizumab

    Pemetrexed

    Pemetrexed for injection

    Penile cancer

    Pertuzumab

    Petupitant and palonosetron

    Pheochromocytoma

    Pityriasis lichenoides et varioliformis acuta

    Pleuropulmonary blastoma

    Pralatrexate

    Precision medicine can widen cancer care options, studies find

    Precision medicine demonstrates benefit in late-stage cancer trial

    Precision Medicine is hot topic at ASCO

    Precision medicine the theme at world’s biggest cancer conference

    Prostate cancer

    Quadrivalent human papillomavirus

    Radium Ra 223 dichloride

    Raloxifene hydrochloride

    Ramucirumab

    Rasburicase

    Regorafenib

    Regorafenib

    Renal cell carcinoma

    Retinoblastoma

    Revolutionary test can tailor the best therapy for cancer patients

    Rhabdomyosarcoma

    Rolapitant

    Romidepsin

    Sardinia has chosen the Oncofocus test for its patients

    Secretin

    Sézary disease

    Sipuleucel-T

    Skin cancer

    Soft-tissue sarcoma

    Sonidegib

    Sorafenib

    Sorafenib

    Sunitinib

    Sunitinib malate

    Talimogene laherparepvec

    Targeted cancer care to spare thousands of patients chemotherapy

    Tbo-filgrastim

    Temozolomide

    Temsirolimus

    Testicular cancer

    The cancer revolution: Personalised treatment that’s ‘six times better’ than traditional methods at beating the disease

    THE ONCOFOCUS TEST

    The personalisation of cancer treatments is leading to better outcomes for patients

    There’s a real sense of optimism around new ways of tackling lung cancer

    Thymoma

    Thyroid cancer

    Topotecan hydrochloride

    Topotecan hydrochloride

    Tositumomab

    Trabectedin

    Trametinib

    Trastuzumab

    Trifluridine and tipiracil

    Triptorelin pamoate

    Tucatinib (ONT-380) progressing in pivotal trial against HER2+ breast cancer

    Two combination therapies shrink melanoma brain metastases in more than half of patients

    UK chief medical officer calls for gene testing revolution within five years. But the revolution is actually already here.

    Uveal melanoma

    Vaginal cancer

    Vandetanib

    Vemurafenib

    Vismodegib

    Vulvar cancer

    Wilms’ tumour

    World Cancer Day 2017

    Ziv-aflibercept

    Zoledronic acid

    Zoledronic acid